Originalartikel | erschienen - Druck | peer reviewed | Open Access
Prevalence of SARS-CoV-2 IgG antibodies among dental teams in Germany
Clinical Oral Investigations
2022 / Mai
;
26(5):
3965 - 3974
Bibliometrische Indikatoren
Impact Factor = 3,4
Zitierhäufigkeit nach WOS = 12
DOI = 10.1007/s00784-021-04363-z
PubMed-ID = 35015149
Autoren
Mksoud M*1, Ittermann T2, Holtfreter B3, Söhnel A4, Söhnel C1, Welk A3, Ulm L5, Becker K5, Hübner N6, Rau A1, Kindler S1, Kocher T3
Beteiligte Einrichtungen
1 - Zentrum für Zahn-, Mund- und Kieferheilkunde / Klinik und Poliklinik für Mund-Kiefer-Gesichtschirurgie/Plastische Operationen
2 - Institut für Community Medicine / Abt. SHIP KEF
3 - Zentrum für Zahn-, Mund- und Kieferheilkunde / Poliklinik für Zahnerhaltung, Parodontologie und Endodontologie
4 - Zentrum für Zahn-, Mund- und Kieferheilkunde / Poliklinik für Zahnärztliche Prothetik, Alterszahnheilkunde und Medizinische Werkstoffkunde
5 - Friedrich Loeffler Institut für Medizinische Mikrobiologie
6 - Institut für Hygiene und Umweltmedizin
Abstract
Objectives: During the corona pandemic, dental practices temporarily closed their doors to patients except for emergency treatments. Due to the daily occupational exposure, the risk of SARS-CoV-2 transmission among dentists and their team is presumed to be higher than that in the general population. This study examined this issue among dental teams across Germany.
Materials and methods: In total, 2784 participants provided usable questionnaires and dry blood samples. Dry blood samples were used to detect IgG antibodies against SARS-CoV-2. The questionnaires were analyzed to investigate demographic data and working conditions during the pandemic. Multivariable logistic mixed-effects models were applied.
Results: We observed 146 participants with positive SARS-CoV-2 IgG antibodies (5.2%) and 30 subjects with a borderline finding (1.1%). Seventy-four out of the 146 participants with SARS-CoV-2 IgG antibodies did not report a positive SARS-CoV-2 PCR test (50.7%), while 27 participants without SARS-CoV-2 IgG antibodies reported a positive SARS-CoV-2 PCR test (1.1%). Combining the laboratory and self-reported information, the number of participants with a SARS-CoV-2 infection was 179 (6.5%). Though after adjustment for region, mixed-effects models indicated associations of use of rubber dams (OR 1.65; 95% CI: 1.01-2.72) and the number of protective measures (OR 1.16; 95% CI: 1.01-1.34) with increased risk for positive SARS-CoV-2 status, none of those variables was significantly associated with a SARS-CoV-2 status in fully adjusted models.
Conclusions: The risk of SARS-CoV-2 transmission was not higher among the dental team compared to the general population.
Veröffentlicht in
Clinical Oral Investigations
| Jahr | 2022 |
| Monat/Hj. | Mai |
| Impact Factor (2022) | 3,4 |
| Volume | 26 |
| Issue | 5 |
| Seiten | 3965 - 3974 |
| Open Access | ja |
| Peer reviewed | ja |
| Artikelart | Originalartikel |
| Artikelstatus | erschienen - Druck |
| DOI | 10.1007/s00784-021-04363-z |
| PubMed-ID | 35015149 |
Allgemeine Daten zur Fachzeitschrift
Kurzbezeichnung: CLIN ORAL INVEST
ISSN: 1432-6981
eISSN: 1436-3771
Land: GERMANY (FED REP GER)
Sprache: English
Kategorie(n):
Impact Factor Entwicklung
ISSN: 1432-6981
eISSN: 1436-3771
Land: GERMANY (FED REP GER)
Sprache: English
Kategorie(n):
- DENTISTRY, ORAL SURGERY & MEDICINE
Impact Factor Entwicklung
| Jahr | Impact Factor |
|---|---|
| 2008 | 1,953 |
| 2009 | 2,233 |
| 2010 | 2,25 |
| 2011 | 2,364 |
| 2012 | 2,2 |
| 2013 | 2,285 |
| 2014 | 2,352 |
| 2015 | 2,207 |
| 2016 | 2,308 |
| 2017 | 2,386 |
| 2018 | 2,453 |
| 2019 | 2,812 |
| 2020 | 3,573 |
| 2021 | 3,606 |
| 2022 | 3,4 |
| 2023 | 3,1 |
| 2024 | 3,1 |
Forschungsschwerpunkt der Universität
Beteiligte Departments
Community Medicine
Projekte
Vorkommen von SARS-CoV-2 Antikörpern bei Zahnärzten (ZOVID)
FAQs | Impressum | Datenschutz

